No Data
COFCO Biotechnology (000930.SZ): not involved in hog farming business
Gelonghui November 6th | Cofco Biotechnology (000930.SZ) stated on the investor interaction platform that the company is not involved in hog farming business.
COFCO Biotechnology (000930.SZ): Intends to upgrade and transform the thermal power system and supporting engineering of COFCO Biochemical Energy (Longjiang) Co., Ltd.
On November 4th, cofco biotechnology (000930.SZ) announced that, in order to promote the low-carbon development of electric machines and to enhance cost reduction and efficiency improvement of the enterprise, as well as to increase the competitiveness of the enterprise, it plans to upgrade and renovate the thermal power system and supporting facilities of cofco bioenergy (Longjiang) Co., Ltd. The total investment for this project is 144.76 million yuan, with construction investment of 140.96 million yuan and construction period interest of 3.8 million yuan. The funds will be sourced from bank loans of 98.67 million yuan and 46.09 million yuan from the enterprise's own funds.
Cofco Biotechnology (000930.SZ): intends to increase the capital of Jilin Cofco Biochemical Packaging Co., Ltd. by 48 million yuan.
Gelonghui November 4th | Cofco Biotechnology (000930.SZ) announced that, due to the continued low demand in the downstream market and reduced use of packaging materials, Jilin Cofco Biochemical Packaging Co., Ltd.'s profitability has decreased, its working capital has been squeezed, the asset-liability ratio continues to rise. The company plans to increase the capital of Jilin Cofco Biochemical Packaging Co., Ltd. with its own funds of 48 million yuan. Jilin Cofco Biochemical Packaging Co., Ltd. is a wholly-owned subsidiary of Changheng Co., Ltd. controlled by the company. This capital increase will be contributed by Changheng Co., Ltd. with 31 million yuan and Cofco Biotechnology Co., Ltd. with 17 million yuan. After the capital increase is completed,
COFCO Technology: Report for the third quarter of 2024
Cofco Biotechnology (000930.SZ) released its performance for the first three quarters, with a net income of 9.605 million yuan, a year-on-year increase of 102.89%.
Cofco Biotechnology (000930.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue...
Cofco Biotechnology (000930.SZ): The net income for the first three quarters was 9.605 million yuan, a year-on-year increase of 102.89%.
On October 25, Glodon News: cofco biotechnology (000930.SZ) released its third quarter report. In the first three quarters of 2024, the company achieved revenue of 15.124 billion yuan, a year-on-year increase of 2.74%; net income attributable to shareholders of the listed company was 9.605 million yuan, a year-on-year increase of 102.89%; net loss after deducting non-recurring gains and losses was 40.1558 million yuan, a year-on-year increase of 89.24%; basic earnings per share was 0.0052 yuan/share.
